Improved Workstation Readability A screening revolution has arrived. The difference is ProFound. Cancer’s hiding place, exposed. Delivering clarity, confidence, and peace of mind. ProFound is clinically proven to improve breast cancer detection and radiologist performance. FDA Cleared. CE Marked. Health Canada Licensed. Discover the Improved Readability in ProFound AI Detection. Radiologists Asked. We Delivered. New features help radiologists quickly identify suspicious lesions by limiting the number of marks on each 3D view, and understand the level of suspicion related to lesions and the case through color-coded scoring ranges. Improved Readability on Workstation: • Limited number of marks • Color-coded lesion marks • Color-coded scorecard Clinical Results 23% relative increase in cancer detection rate without increasing the rate of recalls.1

ProFound AI Detection v3 Service Pack Max of 3 lesion marks per view Focus on the most critical lesion marks. ProFound AI Detection limits the number of marks to three per view* by default, always marking the highest scoring three lesions. Option can be disabled. * With no impact to Specificity and minimal impact to Sensitivity (0%-<0.8% by vendor), based on tests against iCAD’s regulatory dataset. Quickly assess Scorecard & Lesion Mark insights during exam reading. Lesion marks are scored as low (0-19), intermediate (20-69), or high (70-100) level of suspicion of breast cancer and color-coded...